Bristol-Myers Squibb Licenses Three of Aureus Pharma’s Databases | GenomeWeb
NEW YORK (GenomeWeb News) - Aureus Pharma said today that Bristol-Myers Squibb will license three of its databases.
 
Under the agreement, BMS has renewed its license for Aureus’ AurScope GPCR, and it has signed new agreements to license the AurScope Kinase and Ion Channel Knowledge databases as well.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.